Autophagy Plays a Critical Role in ChLym-1-Induced Cytotoxicity of Non-Hodgkin's Lymphoma Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fan, Jiajun ^a   Zeng, Xian ^a   Li, Yubin ^a,b   Wang, Shaofei ^a   Wang, Ziyu ^a   Sun, Yun ^a   Gao, Hongjian ^a   Zhang, Guoping ^a   Feng, Meiqing ^a   Ju, Dianwen ^a  

^a FUDAN UNIVERSITY   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; AMMONIUM CHLORIDE; AUTOPHAGY PROTEIN 5; CASPASE 9; CHIMERIC ANTIBODY; CHLYM 1 ANTIBODY; HLA ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL GROWTH; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOTOXICITY; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; PROTEIN FUNCTION; PROTEIN TARGETING; RAJI CELL; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMMONIUM CHLORIDE; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LYMPHOMA, NON-HODGKIN; MAP KINASE SIGNALING SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASES; SIROLIMUS;

EID: 84883166295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072478     Document Type: Article

References (44)

1. Younes A, Berry DA, (2012) From drug discovery to biomarker-driven clinical trials in lymphoma. Nat Rev Clin Oncol 9: 543-53.
2. Liu C, DeNardo G, Tobin E, DeNardo S, (2004) Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells. Cancer Biother Radiopharm 19: 545-61.
3. Ottonello L, Epstein AL, Mancini M, Amelotti M, Dapino P, et al. (2000) Monoclonal Lym-1 antibody-targeted lysis of B lymphoma cells by neutrophils. Evidence for two mechanisms of FcgammaRII-dependent cytolysis. J Leukoc Biol 68: 662-8.
4. DeNardo GL, Natarajan A, Hok S, Perkins J, Cosman M, et al. (2007) Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma. J Nucl Med 48: 1338-47.
5. Zhang N, Khawli LA, Hu P, Epstein AL, (2007) Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors. Cancer Biother Radiopharm 22: 342-56.
6. Tanida I, (2011) Autophagy basics. Microbiol Immunol 55: 1-11.
7. Rabinowitz JD, White E, (2010) Autophagy and metabolism. Science 330: 1344-8.
8. Jin S, White E, (2007) Role of autophagy in cancer: management of metabolic stress. Autophagy 3: 28-31.
9. Yang ZJ, Chee CE, Huang S, Sinicrope FA, (2011) The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10: 1533-41.
10. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, et al. (2009) Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16: 761-71.
11. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA, (2009) Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS One 4: e6251.
12. Li X, Lu Y, Pan T, Fan Z, (2010) Roles of autophagy in cetuximab-mediated cancer therapy against EGFR. Autophagy 6: 1066-77.
13. Gozuacik D, Kimchi A, (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-906.
14. Yang YP, Liang ZQ, Gao B, Jia YL, Qin ZH, (2008) Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. Acta Pharmacol Sin 29: 123-34.
15. Li X, Fan Z, (2010) The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex. Cancer Res 70: 5942-52.
16. Laplante M, Sabatini DM, (2012) mTOR signaling in growth control and disease. Cell 149: 274-93.
17. O'Brien TF, Zhong XP, (2012) The role and regulation of mTOR in T-lymphocyte function. Arch Immunol Ther Exp (Warsz) 60: 173-81.
18. Gomez-Pinillos A, Ferrari AC (2012) mTOR signaling pathway and mTOR inhibitors in cancer therapy. Hematol Oncol Clin North Am 26: 483-505, vii.
19. Kang R, Zeh HJ, Lotze MT, Tang D, (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18: 571-80.
20. Zhou F, Yang Y, Xing D, (2011) Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 278: 403-13.
21. Liang C, Feng P, Ku B, Oh BH, Jung JU, (2007) UVRAG: a new player in autophagy and tumor cell growth. Autophagy 3: 69-71.
22. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, et al. (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117: 326-36.
23. Kumari S, Mehta SL, Li PA, (2012) Glutamate induces mitochondrial dynamic imbalance and autophagy activation: preventive effects of selenium. PLoS One 7: e39382.
24. Chan LL, Shen D, Wilkinson AR, Patton W, Lai N, et al. (2012) A novel image-based cytometry method for autophagy detection in living cells. Autophagy 8: 1371-82.
25. Barsouk A, Peele KA, Kiljanski J, Stolarski C, Nebes V, et al. (1996) Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction. J Endocrinol Invest 19: 334-41.
26. Bil J, Winiarska M, Nowis D, Bojarczuk K, Dabrowska-Iwanicka A, et al. (2010) Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity. Blood 115: 3745-55.
27. Liu C, Yu K, Shi X, Wang J, Lam PK, et al. (2007) Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aquat Toxicol 82: 135-43.
28. Liu Y, Zhang S, Cai Y, (2007) Cytoprotective effects of selenium on cadmium-induced LLC-PK1 cells apoptosis by activating JNK pathway. Toxicol In Vitro. 21: 677-84.
29. Tobin E, Denardo G, Zhang N, Epstein AL, Liu C, et al. (2007) Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines. Leuk Lymphoma 48: 944-56.
30. Shi WY, Xiao D, Wang L, Dong LH, Yan ZX, et al. (2012) Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy Cell Death Dis. 3: e275.
31. Huang JJ, Li HR, Huang Y, Jiang WQ, Xu RH, et al. (2010) Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy 6: 777-83.
32. Zang L, Xu Q, Ye Y, Li X, Liu Y, et al. (2012) Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells. Arch Biochem Biophys 518: 31-41.
33. Nicotra G, Mercalli F, Peracchio C, Castino R, Follo C, et al. (2010) Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod Pathol 23: 937-50.
34. Chen Y, Azad MB, Gibson SB, (2010) Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol 88: 285-95.
35. Heckmann BL, Yang X, Zhang X, Liu J, (2012) The autophagic inhibitor 3-methyladenine (3-MA) potently stimulates PKA-dependent lipolysis in adipocytes. Br J Pharmacol 168: 163-71.
36. Ibanez E, Agliano A, Prior C, Nguewa P, Redrado M, et al. (2012) The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity. Curr Med Chem 19: 3031-43.
37. Walker CL, Walker MJ, Liu NK, Risberg EC, Gao X, et al. (2012) Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury. PLoS One 7: e30012.
38. Bravo-San Pedro JM, Niso-Santano M, Gomez-Sanchez R, Pizarro-Estrella E, Aiastui-Pujana A, et al. (2013) The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway. Cell Mol Life Sci 70: 121-36.
39. Zeng Y, Yang X, Wang J, Fan J, Kong Q, et al. (2012) Aristolochic acid I induced autophagy extenuates cell apoptosis via ERK 1/2 pathway in renal tubular epithelial cells. PLoS One 7: e30312.
40. Park KJ, Lee SH, Lee CH, Jang JY, Chung J, et al. (2009) Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem Biophys Res Commun 382: 726-9.
41. Li Y, Zhu H, Zeng X, Fan J, Qian X, et al. (2013) Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells. Mol Neurobiol. 47: 1000-10.
42. Heckmann BL, Yang X, Zhang X, Liu J, (2012) The autophagic inhibitor 3-methyladenine (3-MA) potently stimulates PKA-dependent lipolysis in adipocytes. Br J Pharmacol 168: 163-71.
43. Cheng J, Wei HL, Chen J, Xie B, (2012) Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy. Toxicol Mech Methods 22: 512-9.
44. Singh BN, Kumar D, Shankar S, Srivastava RK, (2012) Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol 84: 1154-63.